What it's for (Indications)
- Propyphenazone + caffeine is indicated for the symptomatic relief of mild to moderate pain.
- This combination analgesic is commonly employed for various acute pain conditions including, but not limited to, headaches (tension-type headaches and certain forms of migraine), dental pain, dysmenorrhea (menstrual cramps), and general musculoskeletal aches.
- The propyphenazone component provides potent analgesic, antipyretic, and anti-inflammatory effects, while caffeine acts as an adjuvant, enhancing the analgesic efficacy and providing a mild central nervous system stimulant effect that may counteract fatigue often associated with pain.
- The selection of this combination should consider the patient's overall health profile and the potential risks associated with pyrazolone derivatives.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The typical adult dosage for propyphenazone + caffeine combination products is usually 1 to 2 tablets, taken orally, up to three times daily, as needed for pain relief. Each tablet commonly contains a fixed dose, for instance, 250 mg of propyphenazone and 50 mg of caffeine. The maximum daily dose should not exceed 6 tablets within a 24-hour period, or as specifically directed by a healthcare professional. It is recommended to administer the medication with or after food to minimize potential gastrointestinal discomfort. Dosage adjustments may be necessary for elderly patients, or those with mild to moderate renal or hepatic impairment, requiring careful consideration and medical supervision. This medication is generally not recommended for prolonged use due to the potential for serious adverse effects. |
Safety & Warnings
Common Side Effects
- Common adverse effects associated with propyphenazone + caffeine may include gastrointestinal disturbances such as nausea, vomiting, dyspepsia, and abdominal pain.
- Due to the caffeine component, patients might experience central nervous system effects like insomnia, nervousness, dizziness, agitation, or palpitations.
- More serious, though less frequent, adverse effects include hypersensitivity reactions (e.
- g.
- , skin rashes, urticaria, angioedema, bronchospasm, anaphylaxis), and gastrointestinal ulceration, bleeding, or perforation, which can be fatal.
- Of significant concern with propyphenazone, a pyrazolone derivative, are severe hematological reactions such as agranulocytosis, leukopenia, thrombocytopenia, and aplastic anemia, which can be life-threatening and require immediate medical intervention upon symptom onset.
- Renal impairment, hepatic dysfunction, and cardiovascular events (e.
- g.
- , hypertension, edema, myocardial infarction, stroke) are also potential serious risks, particularly with prolonged use or in susceptible individuals.
Serious Warnings
- Black Box Warning: SEVERE HEMATOLOGICAL TOXICITY AND OTHER SERIOUS RISKS. Propyphenazone, a pyrazolone derivative, carries a significant and potentially life-threatening risk of severe hematological adverse reactions, most notably agranulocytosis. Agranulocytosis can manifest acutely, regardless of treatment duration, and may be fatal. Patients must be educated on the symptoms of agranulocytosis (e.g., fever, sore throat, oral lesions, flu-like symptoms, chills) and instructed to immediately discontinue the drug and seek urgent medical evaluation if such signs appear. Regular monitoring of blood counts is strongly advised, particularly with prolonged therapy, but does not guarantee prevention of acute agranulocytosis. Furthermore, like other NSAIDs, propyphenazone can cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may increase with duration of use and in patients with pre-existing cardiovascular disease or risk factors. Serious gastrointestinal adverse events, including bleeding, ulceration, and perforation of the stomach or intestines, can occur at any time without warning symptoms and may be fatal. Elderly patients and those with a history of gastrointestinal disease are at greater risk for serious GI events.
- Patients should be advised to discontinue propyphenazone + caffeine and seek immediate medical attention if they experience any signs of severe hematological reactions, such as fever, sore throat, mouth ulcers, flu-like symptoms, or unexplained bruising/bleeding.
- The concurrent use of other NSAIDs, anticoagulants, antiplatelet agents, corticosteroids, or selective serotonin reuptake inhibitors (SSRIs) can increase the risk of gastrointestinal bleeding.
- Caution is advised in patients with a history of gastrointestinal disease, cardiovascular disease, hypertension, renal impairment, or hepatic dysfunction.
- Caffeine intake from other sources (e.
- g.
- , coffee, tea, energy drinks) should be limited to avoid excessive stimulation.
- Prolonged use of this combination should be avoided due to the increased risk of cumulative adverse effects, especially hematological toxicities.
- This medication can mask the signs of infection, potentially delaying appropriate medical treatment.
- Patients should be informed about the signs of hypersensitivity reactions and instructed to cease medication use if they occur.
How it Works (Mechanism of Action)
Propyphenazone, a pyrazolone derivative, exerts its analgesic, antipyretic, and anti-inflammatory effects primarily through the inhibition of cyclooxygenase (COX) enzymes, particularly COX-1 and COX-2. This inhibition leads to a reduced synthesis of prostaglandins, which are key mediators involved in pain, fever, and inflammation pathways. By diminishing prostaglandin production, propyphenazone helps to alleviate pain and reduce elevated body temperature. Caffeine, a central nervous system stimulant and a methylxanthine derivative, acts primarily as an adenosine receptor antagonist. By blocking adenosine receptors, caffeine enhances alertness, reduces fatigue, and contributes to the analgesic effect, particularly in headaches, possibly by causing cerebral vasoconstriction. The combination of these two agents provides a synergistic effect, offering more potent pain relief than either drug alone.